The IPV are very safe. At the site of injection pain or mild redness may occur. To preventfrom Poliomyelitis, which affects children under age of 5. This infection can turn into irreversible paralysis and can also cause death. There are two types of vaccines used: an inactivated poliovirus given by injection (IPV) and a weakened poliovirus given orally (OPV). After two doses of inactivated polio vaccine, 90% or more of individuals develop protective antibodies to all three serotypes, when inactivated polio vaccine injection is used and about 99% are immune to polio virus.
Immunity induced by IPV and its duration is not known with certainty, although to provide protection for several years the complete study has been done. In 1990s IPV replaced the oral vaccines due to risk of vaccine-derived polio in oral vaccines in various countries.
The IPV vaccines market is estimated to be valued at US$ 160 Mn in 2021 and is expected to register a CAGR of 8.5% and reach US$ 240 Mn by 2028.
Figure 1. Global IPV Vaccines Market (US$ Mn), By Vaccine Brand, 2021
Figure 1.1. Global IPV Vaccines Market (US$ Mn), By Vaccine Brand, 2028
IPV Vaccines Market Report Coverage
|Base Year:||2020||Market Size in 2021:||US$ 160 Mn|
|Historical Data for:||2017 to 2020||Forecast Period:||2021 to 2028|
|Forecast Period 2021 to 2028 CAGR:||8.5%||2028 Value Projection:||US$ 240 Mn|
GlaxoSmithKline Plc, Sanofi S.A., Serum Institute of India Pvt. Ltd., PT Bio Farma, and AJ Vaccines
|Restraints & Challenges:||
Figure 2. Global IPV Vaccines Market (US$ Mn), By Region, 2021
Figure 2.1. Global IPV Vaccines Market (US$ Mn), By Region, 2028
For instance, in August 2018, Health Ministry of Brazil launched a polio vaccination campaign in Brazil to immunize more than 11.2 million children aged 5 years. The Health Ministry purchased 28.3 million doses of polio vaccines from Brazilian. Moreover, states in Brazil were supplied 871.3 thousand doses of IPV, and 14 million doses of OPV.
Global IPV Vaccines Market – Impact of Coronavirus (COVID-19) Pandemic
The coronavirus (COVID-19) pandemic is the most recent outbreak, which was first reported on December 31, 2019, in Wuhan, China. The shutdown disrupted the supply, distribution, and manufacturing of medical supplies globally. Moreover, due to social distancing, the footfall in clinics and health institutions has fallen by more than 70% during this pandemic, which has led to decrease in the number of surgical procedures, clinical trials, research and development activities and others, which has negatively impacted the market growth.
Vaccine hesitancy has been considered a problem for polio eradication in past for Pakistan and Afghanistan. The COVID-19 vaccines had made a widespread awareness regarding lifesaving effects of the vaccines, and this effected on the public awareness in polio endemic countries (Gabon, Ghana, Guinea, Liberia, Nigeria). Especially in the tropics there is need for booster doses of polio vaccine. In routine immunizations, there is need to implement GPEIs, for the oral polio vaccines, which can help in reducing the polio cases by more than 90%. To protect the lives of children, the COVID-19 vaccination centers remain ideal to increase the awareness of polio vaccines.
Global IPV Vaccines Market - Restraint
Inactivated polio vaccines are given to millions of children and adults for the prevention of polio. Although, in some cases, this immunization shows side effects including: rash, itching.
According to several research studies, immunization with inactivated polio vaccines are less effective. For instance, inactivated polio vaccines (IPV) weaken immunity in the intestine. Moreover, after immunization with IPV, every person gets infected with wild poliovirus, which multiply in the intestines.
Therefore, these side effects can pose major challenges such as decreasing community acceptance for such inactivated polio vaccines, which in turn is expected to hamper growth of Global Inactivated Polio Vaccines Market.
High cost of inactivated polio vaccines in comparison with oral polio vaccines may negatively impact growth of the inactivated polio vaccines market.
For instance, in 2019, according to the World Health Organization, the weighted average price of IPV vaccines per dose is US$ 2.8 while the price per dose of OPV vaccine ranges from US$ 0.12 to 0.17 in PAHO countries.
Major players operating in the Global IPV vaccines market include GlaxoSmithKline Plc, Sanofi S.A., Serum Institute of India Pvt. Ltd., PT Bio Farma, and AJ Vaccines.
Frequently Asked Questions